GlobalResearch and clinical trials
Intravenous dapirolizumab pegol reduced disease activity in lupus in a phase 3 trial
The trial was conducted in 25 countries with 321 patients with moderate or severe lupus.
Blood and immune system diseases
A long-term disease in which the immune system attacks the body's own tissues. It can affect the skin, joints, kidneys and other organs. Symptoms get worse, then better.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
This page is translated from the Turkish original.
This disease is followed through the “Blood and immune system diseases” group.
The immune system normally protects the body against germs. In lupus, it mistakenly attacks the body's own tissues. This attack leads to inflammation. The skin, joints, kidneys, heart, lungs, nervous system and blood cells can be affected. The disease alternates between flares and calm periods.
Symptoms vary greatly from person to person. They can come and go.
The doctor asks about the symptoms and does an examination. Blood tests look for certain autoantibodies. The ANA test is positive in almost all patients, but this test alone does not make the diagnosis. A urine test, a blood count and, if needed, a kidney biopsy are done.
The aim is to control the symptoms and protect the organs. Treatment is chosen according to how active the disease is and which organs it affects. Medicines that reduce inflammation and suppress the immune system are used. There are also approved biological medicines for lupus. Protecting yourself from the sun, keeping vaccines up to date and stopping smoking are important. Heart and bone health are also checked regularly. The doctor who follows the disease decides which treatment is suitable.
Lupus is usually not a directly inherited disease. Some gene differences may increase the risk. The disease is somewhat more common in some families. A very rare form is inherited recessively. Women thinking about pregnancy should first talk to their doctor. If there are several affected people in the family, genetic counselling can be helpful.
Source: MedlinePlus Genetics: Systemic lupus erythematosus · MedlinePlus: Systemic lupus erythematosus · NHS: Lupus
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
GlobalResearch and clinical trials
The trial was conducted in 25 countries with 321 patients with moderate or severe lupus.
USANew treatments and approvals
The FDA approved obinutuzumab as an add-on to standard treatment in adults with active lupus nephritis.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
Questions you can ask your doctor
ClinicalTrials.gov lists 302 active interventional studies for this disease. 182 are recruiting now; 10 have sites in Türkiye. Last checked: October 7, 2026.
Selected records (studies with a site in Türkiye first):
Late stage: the effect is being compared in a large group · Phase 3 · investigational (experimental)RecruitingSite in TürkiyeNCT07691970
Middle stage: the effect is being tested in a small group · Phase 2 · investigational (experimental)RecruitingSite in TürkiyeNCT05268289
Late stage: the effect is being compared in a large group · Phase 3 · investigational (experimental)RecruitingSite in TürkiyeNCT05835310
Middle stage: the effect is being tested in a small group · Phase 2 · investigational (experimental)Active, not recruitingSite in TürkiyeNCT05039840
Late stage: the effect is being compared in a large group · Phase 3 · investigational (experimental)Active, not recruitingSite in TürkiyeNCT05639114
See all studies on ClinicalTrials.gov · Joining clinical trials
GlobalHealth policy
The International Pediatric Nephrology Association published its recommendations for diagnosing and treating atypical HUS in children.
GlobalResearch and clinical trials
Researchers re-examined the data from a large drug study.
TürkiyeResearch and clinical trials
A face-to-face survey was conducted with 104 PNH patients at 18 centers in Türkiye.
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:536 · ICD-11 4A40.0
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.